A

  • Alternative medicines Complementary and alternative medications usage in patients attending rheumatology clinics: a cross-sectional study [Volume 6, Issue 3, 2021, Pages 139-143]
  • Antirheumatic Agents The prevalence of Covid-19 in patients with Rheumatoid Arthritis receiving classic Disease-Modifying Anti Rheumatic Drugs [Volume 6, Issue 2, 2021, Pages 87-93]
  • Arthritis drug therapy The prevalence of Covid-19 in patients with Rheumatoid Arthritis receiving classic Disease-Modifying Anti Rheumatic Drugs [Volume 6, Issue 2, 2021, Pages 87-93]
  • Asymptomatic Asymptomatic active Paget bone disease: a case report [Volume 6, Issue 1, 2021, Pages 53-57]
  • Autoimmune Disease Interferon regulatory factor 5 in Rheumatoid arthritis and systemic lupus erythematosus [Volume 6, Issue 1, 2021, Pages 1-13]
  • Autoimmune Disease Cutaneous leishmaniasis in patient with polyarteritis nodosa vasculitis: A Case report [Volume 6, Issue 3, 2021, Pages 157-161]

B

  • Behçet’s disease Whether Behçet’s patients with large vessel involvement have concurrent small vessel involvement? A case-control Study [Volume 6, Issue 3, 2021, Pages 151-156]
  • Biomarkers Asymptomatic active Paget bone disease: a case report [Volume 6, Issue 1, 2021, Pages 53-57]

C

  • Cholesterol Association between Abnormal Lipid Levels and Systemic Lupus Erythematosus [Volume 6, Issue 2, 2021, Pages 81-86]
  • Complementary medicines Complementary and alternative medications usage in patients attending rheumatology clinics: a cross-sectional study [Volume 6, Issue 3, 2021, Pages 139-143]
  • COVID-19 Musculoskeletal Manifestations of COVID-19: A Systematic Search and Review [Volume 6, Issue 2, 2021, Pages 59-80]
  • COVID-19 The prevalence of Covid-19 in patients with Rheumatoid Arthritis receiving classic Disease-Modifying Anti Rheumatic Drugs [Volume 6, Issue 2, 2021, Pages 87-93]
  • COVID-19 Immune-mediated necrotizing myositis following SARS-Cov-2: A case report [Volume 6, Issue 3, 2021, Pages 145-149]
  • C-reactive protein Comparison of efficacy of Infliximab and Etanercept on Rheumatoid Arthritis patients [Volume 6, Issue 1, 2021, Pages 35-42]
  • Cutaneous leishmaniasis Cutaneous leishmaniasis in patient with polyarteritis nodosa vasculitis: A Case report [Volume 6, Issue 3, 2021, Pages 157-161]

D

  • Diagnosis Variety and contribution of different rheumatic diseases at rheumatology clinic of a general hospital [Volume 6, Issue 1, 2021, Pages 15-22]

E

  • Epidemiology Variety and contribution of different rheumatic diseases at rheumatology clinic of a general hospital [Volume 6, Issue 1, 2021, Pages 15-22]
  • Erythrocyte Sedimentation Rates Comparison of efficacy of Infliximab and Etanercept on Rheumatoid Arthritis patients [Volume 6, Issue 1, 2021, Pages 35-42]
  • Expression, Regulation miRNAs and rheumatoid arthritis: new update in expression pattern and pathogenicity [Volume 6, Issue 3, 2021, Pages 123-137]

G

  • Gene co-expression network Identification of key genes and pathways for differential diagnosis between rheumatoid arthritis and osteoarthritis based on systems biology approaches [Volume 6, Issue 1, 2021, Pages 23-34]
  • Granulomatosis with polyangiitides Pituitary involvement in a case of granulomatosis with polyangiitis: case report and literature review [Volume 6, Issue 2, 2021, Pages 115-121]

H

  • Helicobacter pylori Comparison of serum and synovial fluid markers of Herpes simplex virus and Helicobacter pylori infection between rheumatoid arthritis and osteoarthritis patients: A Retrospective Case-Control Study [Volume 6, Issue 1, 2021, Pages 43-48]

I

  • Inappropriate ADH Syndrome Syndrome of Inappropriate Secretion of Antidiuretic Hormone and Severe Thrombocytopenia in an Immunosuppressive Systemic Lupus Erythematosus Patient: A Case Report [Volume 6, Issue 2, 2021, Pages 109-114]
  • Inflammation Association between Abnormal Lipid Levels and Systemic Lupus Erythematosus [Volume 6, Issue 2, 2021, Pages 81-86]
  • Inflammatory Biomarker Identification of inflammatory biomarkers in rheumatoid arthritis patients; a case-control study [Volume 6, Issue 2, 2021, Pages 95-98]
  • Interferon regulatory factor 5 (IRF5) Interferon regulatory factor 5 in Rheumatoid arthritis and systemic lupus erythematosus [Volume 6, Issue 1, 2021, Pages 1-13]

K

  • Knee osteoarthritis Variety and contribution of different rheumatic diseases at rheumatology clinic of a general hospital [Volume 6, Issue 1, 2021, Pages 15-22]

L

  • Lipid Association between Abnormal Lipid Levels and Systemic Lupus Erythematosus [Volume 6, Issue 2, 2021, Pages 81-86]

M

  • MSK symptoms Musculoskeletal Manifestations of COVID-19: A Systematic Search and Review [Volume 6, Issue 2, 2021, Pages 59-80]
  • Musculoskeletal Diseases Variety and contribution of different rheumatic diseases at rheumatology clinic of a general hospital [Volume 6, Issue 1, 2021, Pages 15-22]
  • Myositis Immune-mediated necrotizing myositis following SARS-Cov-2: A case report [Volume 6, Issue 3, 2021, Pages 145-149]

N

  • Nail fold capillaroscopy Whether Behçet’s patients with large vessel involvement have concurrent small vessel involvement? A case-control Study [Volume 6, Issue 3, 2021, Pages 151-156]
  • Necrotizing Immune-mediated necrotizing myositis following SARS-Cov-2: A case report [Volume 6, Issue 3, 2021, Pages 145-149]

O

  • Osteitis deformans Asymptomatic active Paget bone disease: a case report [Volume 6, Issue 1, 2021, Pages 53-57]

P

  • Paget's disease of bone Asymptomatic active Paget bone disease: a case report [Volume 6, Issue 1, 2021, Pages 53-57]
  • Periarthritis Variety and contribution of different rheumatic diseases at rheumatology clinic of a general hospital [Volume 6, Issue 1, 2021, Pages 15-22]
  • Plantar fasciitis Variety and contribution of different rheumatic diseases at rheumatology clinic of a general hospital [Volume 6, Issue 1, 2021, Pages 15-22]

R

  • Rheumatic patients Complementary and alternative medications usage in patients attending rheumatology clinics: a cross-sectional study [Volume 6, Issue 3, 2021, Pages 139-143]
  • Rheumatoid arthritis Comparison of efficacy of Infliximab and Etanercept on Rheumatoid Arthritis patients [Volume 6, Issue 1, 2021, Pages 35-42]
  • Rheumatoid arthritis Identification of key genes and pathways for differential diagnosis between rheumatoid arthritis and osteoarthritis based on systems biology approaches [Volume 6, Issue 1, 2021, Pages 23-34]
  • Rheumatoid arthritis Comparison of serum and synovial fluid markers of Herpes simplex virus and Helicobacter pylori infection between rheumatoid arthritis and osteoarthritis patients: A Retrospective Case-Control Study [Volume 6, Issue 1, 2021, Pages 43-48]
  • Rheumatoid arthritis Identification of inflammatory biomarkers in rheumatoid arthritis patients; a case-control study [Volume 6, Issue 2, 2021, Pages 95-98]
  • Rheumatoid arthritis The prevalence of Covid-19 in patients with Rheumatoid Arthritis receiving classic Disease-Modifying Anti Rheumatic Drugs [Volume 6, Issue 2, 2021, Pages 87-93]
  • Rheumatoid arthritis (RA) Interferon regulatory factor 5 in Rheumatoid arthritis and systemic lupus erythematosus [Volume 6, Issue 1, 2021, Pages 1-13]
  • Rheumatoid arthritis (RA) miRNAs and rheumatoid arthritis: new update in expression pattern and pathogenicity [Volume 6, Issue 3, 2021, Pages 123-137]

S

  • SARS-CoV-2 Immune-mediated necrotizing myositis following SARS-Cov-2: A case report [Volume 6, Issue 3, 2021, Pages 145-149]
  • Synovial fluid Comparison of serum and synovial fluid markers of Herpes simplex virus and Helicobacter pylori infection between rheumatoid arthritis and osteoarthritis patients: A Retrospective Case-Control Study [Volume 6, Issue 1, 2021, Pages 43-48]
  • Systematic review Musculoskeletal Manifestations of COVID-19: A Systematic Search and Review [Volume 6, Issue 2, 2021, Pages 59-80]
  • Systemic lupus erythematosus Syndrome of Inappropriate Secretion of Antidiuretic Hormone and Severe Thrombocytopenia in an Immunosuppressive Systemic Lupus Erythematosus Patient: A Case Report [Volume 6, Issue 2, 2021, Pages 109-114]
  • Systemic lupus erythematosus The association of main blood groups and development of Systemic Lupus Erythematosus and its organ involvements [Volume 6, Issue 2, 2021, Pages 99-107]
  • Systemic lupus erythematosus Association between Abnormal Lipid Levels and Systemic Lupus Erythematosus [Volume 6, Issue 2, 2021, Pages 81-86]

V

  • Vascular involvement Whether Behçet’s patients with large vessel involvement have concurrent small vessel involvement? A case-control Study [Volume 6, Issue 3, 2021, Pages 151-156]

W

  • Wegener Granulomatosis Pituitary involvement in a case of granulomatosis with polyangiitis: case report and literature review [Volume 6, Issue 2, 2021, Pages 115-121]
  • Wegener' s Granulomatosis Pituitary involvement in a case of granulomatosis with polyangiitis: case report and literature review [Volume 6, Issue 2, 2021, Pages 115-121]